Medscape Medical News: Deborah Brauser
January 13, 2010 (Miami, Florida) — Aerosolized bronchodilators are independently associated with an increased risk for ventilator-associated pneumonia (VAP) in critically ill patients, according to results from an observational study presented here at the Society of Critical Care Medicine 39th Critical Care Congress.
Lead author Saad Nseir, MD, from the Medical Intensive Care Unit (ICU) at Calmette Hospital, CHRU, in Lille, France, reported during his oral presentation that although bronchodilator use has increased for mechanically ventilated patients, past studies "have suggested that aerosol therapy may promote bacterial colonization of ventilator circuit and subsequent VAP."
Society of Critical Care Medicine (SCCM) 39th Critical Care Congress: Abstract 10. Presented January 10, 2010.
Weblink here